HC Wainwright upgraded shares of Kitov Pharmaceuticals Holdings Ltd. (NASDAQ:KTOV) from a neutral rating to a buy rating in a research note published on Tuesday, MarketBeat reports. The firm currently has $10.00 price target on the stock.

Shares of Kitov Pharmaceuticals Holdings (NASDAQ KTOV) traded up $0.14 during trading on Tuesday, reaching $2.32. The company had a trading volume of 501,600 shares, compared to its average volume of 248,139. Kitov Pharmaceuticals Holdings has a 52 week low of $1.27 and a 52 week high of $3.78.

WARNING: “Kitov Pharmaceuticals Holdings Ltd. (KTOV) Lifted to Buy at HC Wainwright” was posted by Watch List News and is the sole property of of Watch List News. If you are accessing this piece on another domain, it was illegally copied and reposted in violation of U.S. & international copyright legislation. The legal version of this piece can be viewed at https://www.watchlistnews.com/kitov-pharmaceuticals-holdings-ltd-ktov-lifted-to-buy-at-hc-wainwright/1723923.html.

Kitov Pharmaceuticals Holdings Company Profile

Kitov Pharmaceuticals Holdings Ltd is an Israel-based company that develops non-steroidal anti-inflammatory drugs that treat pain without raising blood pressure, thus avoiding the increased risk of heart attacks, strokes or death.

Receive News & Ratings for Kitov Pharmaceuticals Holdings Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kitov Pharmaceuticals Holdings Ltd. and related companies with Analyst Ratings Network's FREE daily email newsletter.